Real World Experience: Impact of a Specialist Interstitial Lung Disease Nurse on Health Care Utilization

Real World Experience: Impact of a Specialist Interstitial Lung Disease Nurse on Health Care Utilization

Saved in:

Bibliographic Details
Main Authors:	Onofre Morán-Mendoza, Mohamed Khalil, Sharina Aldhaheri, Jiayi Xing, Ana P. Johnson
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Series:	Open Respiratory Archives
Online Access:	http://www.sciencedirect.com/science/article/pii/S2659663625000049
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Specialist journalism /
Published: (2013)

Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype
by: Xinzhi Xu, et al.
Published: (2025-02-01)

The Real-World Utilization Pattern of Increased Utilization of Advanced Topical Adjunctive Hemostats in a Vertically Integrated Healthcare System
by: Lee Stern, et al.
Published: (2017-01-01)

Reference values for the 1-minute sit-to-stand test to assess functional capacity and short-term mortality in people with idiopathic pulmonary fibrosis and fibrotic connective tissue related interstitial lung diseases: a prospective real-world cohort study
by: Meng-Yun Tsai, et al.
Published: (2025-02-01)

Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international survey
by: Emil Vilstrup Moen, et al.
Published: (2025-02-01)

A study to correlate the association of Gender, Age, Physiology (GAP) index and radiological patterns in interstitial lung disease
by: Aditya Shashi Bhushan, et al.
Published: (2025-01-01)

Clinical characteristics and prognosis of amyopathic dermatomyositis patients with interstitial lung disease: insights from a retrospective cohort
by: Yanan Ying, et al.
Published: (2025-02-01)

Effect of noninvasive respiratory support on interstitial lung disease with acute respiratory failure: A systematic review and meta-analysis
by: Natthawan Sanguanwong, et al.
Published: (2023-11-01)

Derivation of a simple risk calculator for predicting clinical worsening in patients with pulmonary hypertension due to interstitial lung disease
by: K. El-Kersh, et al.
Published: (2025-02-01)

Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer
by: Ji Eun Shin, et al.
Published: (2025-02-01)

Development of delayed pulmonary toxicities and transcriptional changes in pre-existing interstitial lung disease mice after partial thoracic irradiation
by: Jiamei Fu, et al.
Published: (2025-02-01)

Real World Evaluation of Next-Day Molecular Respiratory Infectious Disease Testing on Healthcare Resource Utilization and Costs
by: French AJ, et al.
Published: (2025-02-01)

The Implications of Mental Health and Trauma in Interstitial Cystitis
by: Tyler R. Bendrick, et al.
Published: (2022-11-01)

Efficacy and safety of antifibrotic drugs for interstitial lung diseases other than IPF: A systematic review, meta-analysis and trial sequential analysis.
by: Mei Yang, et al.
Published: (2025-01-01)

Workforce utilization of Canadian men with a nursing education
by: Christoph Schimmele, et al.
Published: (2024-09-01)

USE OF GEOINFORMATION TECHNOLOGIES IN DISTANCE LEARNING OF FUTURE SPECIALISTS IN GEOGRAPHY
by: Vasyl V. Leta, et al.
Published: (2023-06-01)

APPLICATION OF ARTIFICIAL INTELLIGENCE FOR IMPROVING SITUATIONAL TRAINING OF CYBERSECURITY SPECIALISTS
by: Yurii V. Shchavinsky, et al.
Published: (2023-10-01)

The aspects of the transdisciplinary cooperation in the training of the specialists in the field of Information Technologies
by: Edita Butrimienė, et al.
Published: (2023-09-01)

29-year-old patient with interstitial pulmonary disease and diarrhea
by: Nino D. Potskhverashvili, et al.
Published: (2016-08-01)

Real-world pharmacovigilance analysis unveils the toxicity profile of amivantamab targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
by: Jing Zhang, et al.
Published: (2025-02-01)

Very first real-world data on zongertinib use in non-small cell lung cancer patients with HER2 mutations: A brief report
by: Oliver Illini, et al.
Published: (2024-01-01)

Comparison of specialist ataxia centres with non-specialist services in terms of care access and organisation, health services resource utilisation and costs in Germany using patient-reported data
by: Julie Vallortigara, et al.
Published: (2025-02-01)

Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study
by: Egbert F Smit, et al.
Published: (2025-02-01)

Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States
by: Ehab L. Atallah, et al.
Published: (2022-08-01)

Using Real World Evidence to Describe Pulmonary Arterial Hypertension Treatment Patterns, Healthcare Resource Utilization, and Costs Associated with PDE-5 Inhibitor Monotherapy
by: George Ruiz, et al.
Published: (2018-01-01)

52-year-old patient with interstitial pneumonia, dysphagia and Reynaud's syndrome
by: D. Ye. Rumyantseva, et al.
Published: (2018-08-01)

Assessing The Factors Affecting The Utilization of Electronic Records in Nursing Schools: A Case Study Of Kabale School of Comprehensive Nursing.
by: Tumwijukye, Warren
Published: (2024)

Real-world effectiveness of sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir against genotype 3 hepatitis C virus infection: a systematic review and meta-analysis
by: Liwei Zhuang, et al.
Published: (2025-02-01)

Adverse events in the nervous system associated with blinatumomab: a real-world study
by: Wen Gao, et al.
Published: (2025-02-01)

THE PUBLIC HEALTH IMPLICATION OF PATIENT’S RIGHT ABUSE BY HEALTH PROFESSIONALS IN PLATEAU SPECIALIST HOSPITAL, JOS
by: Emmanuel Mahanan Josiah
Published: (2023-07-01)

Impact of COVID-19 on orthopaedic specialist training: a nationwide survey of orthopaedic residents in Singapore
by: Hwee Weng Dennis Hey, et al.
Published: (2024-03-01)

Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system
by: Ruichen Gao, et al.
Published: (2025-02-01)

Real-world effectiveness of azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19 and pre-existing diabetes
by: Guanyue Su, et al.
Published: (2025-02-01)

The real world guide to psychotherapy practice by Alex N. Sabo & Leston Havens (Eds.)
by: P. M. Heyns
Published: (2002-12-01)

Real world study on combining local interventions with systemic therapy in unresectable hepatocellular carcinoma
by: Zhaosong Xue, et al.
Published: (2025-02-01)

Real-world pharmacovigilance study of drug-induced autoimmune hepatitis from the FAERS database
by: Bu-kun Zhu, et al.
Published: (2025-02-01)

Real-World Effectiveness of Portable Air Cleaners in Reducing Home Particulate Matter Concentrations
by: Frederic T. Lu, et al.
Published: (2023-11-01)

Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR
by: Mike Durkin, et al.
Published: (2015-07-01)

Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel
by: Keith L. Davis, et al.
Published: (2015-01-01)

Real world federated learning with a knowledge distilled transformer for cardiac CT imaging
by: Malte Tölle, et al.
Published: (2025-02-01)